AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Czech Republic

552/2025 Sb.

Government Regulation on conditions for prescribing, dispensing and using individually prepared medicinal products containing psilocybin for medical use [Nařízení vlády o podmínkách pro předepisování, výdej a používání individuálně připravovaných léčivých přípravků s obsahem psilocybinu pro léčebné použití]

Status

Enacted

2025

The government regulation sets conditions for prescribing, dispensing and using individually prepared psilocybin medicines.

IntroducedDate TBC (done)
PassedDate TBC (done)
SignedDec 10, 2025 (done)
Law in effectJan 1, 2026 (done)

Official text

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: e-sbirka.gov.cz

Legislative history

No dated actions recorded yet. The progress steps above show what is confirmed.

Loading bill…